Laura Benjamin
Net worth: - $ as of 31/05/2026
Net worth: - $ as of 31/05/2026
Laura E.
Benjamin was the founder of Oncxerna Therapeutics, Inc., founded in 2018, where the titles held included President, Chief Executive Officer & Director from 2018 to 2023.
The current jobs include Independent Director at Allarity Therapeutics A and Independent Director at Allarity Therapeutics, Inc. starting in 2023.
The education history includes a doctorate from the University of Pennsylvania and an undergraduate degree from Barnard College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/01/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Director/Board Member | 01/01/2023 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Develops cancer medications | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Founder | 01/08/2023 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barnard College
Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Develops cancer medications | Health Technology |
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions